Our results showed significantly higher serum LOXL2 level in PID patients compared to age-matched healthy women, and significantly higher serum LOXL2 level in PID patients with pelvic adhesion compared to patients without pelvic adhesion. Here, LOXL2 is linked to pelvic inflammatory disease.